Clinical Trial

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Name: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma — clinical trial record (NCT07288203)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase 2, multicenter, open-label study of lifileucel (tumor-infiltrating lymphocytes \[TIL\]) in participants with previously treated advanced melanoma

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-21

Trial Details

NCT Number	NCT07288203
Lead Sponsor	Iovance Biotherapeutics, Inc.
Conditions	Melanoma (Skin Cancer), Unresectable Melanoma, Metastatic Melanoma
Enrollment	100 participants
Start Date	2025-11-28
Primary Completion	2032-12 (estimated)
Study Completion	2033-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-20